PQDx 0141-051-00 WHO
PQDx Public Report
April/2017, version 5.0
Accessed: 08.03.2020
Facilitating means a lot of things. The table below provides an outline of the topics discussed in this section:
- Know Your Audience
- Apply Adult Learning Principles
- Be Prepared to Train
- Manage the Training
- Communicate Effectively
- Engage the Participants
-Use... Visual Aids Effectively
Section 3: Training Basics, Trainer’s Guide
more
Des milliers de personnes meurent chaque jour des suites d’infections acquises au cours des procédures de soins.
Esta “Guía para la elaboración a nivel local de formulaciones recomendadas por la OMS para la desinfección de las manos”, está dividida en dos secciones específicas, relacionadas entre sí
Risk Communication and Community Engagement messages
Com o tema A equidade, o coração da saúde, este Plano busca catalisar esforços nos Estados Membros para reduzir as iniquidades em saúde dentro dos países e territórios e entre eles, a fim de melhorar os resultados em termos de saúde. O Plano identifica ações específicas para enfrentar a d...esigualdade em saúde, como as recomendadas pela Comissão sobre Equidade e Desigualdades em Saúde nas Américas, com a orientação da Comissão de Alto Nível para a Saúde Universal. Quatro temas transversais são centrais para o enfoque deste Plano para abordar os determinantes da saúde: a equidade, o gênero, a etnia e os direitos humanos.
more
This document is part three in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. Part two focused on the ingredients in a vaccine and the three clinical trial phases.
This document outlines the... next part of the vaccine journey: the steps from completing the clinical trial phases through to distribution.
more
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This... policy brief was developed by the WHO Access to COVID-19 Tools (ACT) Accelerator Ethics & Governance Working Group, to provide guidance for researchers, sponsors, regulators, research ethics committees, and policy-makers, on these and related issues.
more
Despite recommendations on the marketing of commercial baby and toddler foods, two new reports from WHO find widespread evidence of inappropriate promotion and poor nutritional quality of foods for infants and young children across the WHO European Region. To address these issues and help countries ...implement nutrition recommendations, a nutrient profile model is proposed to guide decisions on promotion and nutrition quality of baby foods.
more
Adaptable guidance, tools, trainings, and advocacy materials are being developed to support countries in preparing for COVID-19 vaccination. Please visit this page regularly for updates.
The Country Readiness and Delivery(CRD) workstream which is part of the ACT Accelerator and is included in the SPRP– has developed a toolbox with guidance, tools and training.
The WHO COVID-19 LENS (Living Evidence Synthesis) working group consolidated available evidence, based on rapid reviews of the literature and results of a living systematic review on pregnancy and COVID-19 (up to October 7, 2020), on potential mechanisms of vertical transmission of infectious pathog...ens, feasibility of vertical transmission of SARS-CoV-2, data related to interpretation of positive SARS-CoV-2 virologic and serologic neonatal tests, lessons from diagnosis of other congenital infections, and existing proposed definitions to classify timing of vertical transmission of SARS-CoV-2.
more
“Preferred product characteristics” (PPCs) are key tools to incentivize and guide the development of urgently needed health products. Some of the vector control interventions deployed in complex emergencies and in response to natural disasters ... namely insecticide-treated nets (ITNs) and indoor residual spraying (IRS) – have already met identified public health needs in more stable settings; other tools such as insecticide-treated tarpaulins have been specifically designed for this use case. Given the diverse mix of existing and potential new interventions and the considerable gaps in the associated evidence base, this PPC aims to clearly articulate the unmet public health needs for tools designed to control malaria transmission in complex emergencies and in response to natural disasters.
more
7 April 2021
Based on current information, a causal relationship between the vaccine and the occurrence of blood clots with low platelets is considered plausible but is not confirmed.
Available in Englisch, French and Russian
Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi.
AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines making infections ha...rder to treat and increasing the risk of disease spread, severe illness and death. As a result, the medicines become ineffective and infections persist in the body, increasing the risk of spread to others.
Antimicrobials - including antibiotics, antivirals, antifungals and antiparasitics - are medicines used to prevent and treat infections in humans, animals and plants. Microorganisms that develop antimicrobial resistance are sometimes referred to as “superbugs”.
more